Algernon Logo 1.png
Algernon Pharmaceuticals’ NP-120 Reduced Fibrosis in an Idiopathic Pulmonary Fibrosis Study by 56% Outperforming USFDA Approved Treatments Nintedanib and Pirfenidone
03 juil. 2019 07h00 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, July 03, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “Company” or “Algernon”), a clinical stage pharmaceutical...
TreviLogo.png
Trevi Therapeutics to Present at BMO Prescriptions for Success Healthcare Conference
18 juin 2019 16h05 HE | Trevi Therapeutics
NEW HAVEN, Conn., June 18, 2019 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine...
TreviLogo.png
Trevi Therapeutics Announces First Quarter 2019 Financial Results and Recent Business Developments
13 juin 2019 16h09 HE | Trevi Therapeutics
Raised $70 Million in Gross Proceeds from Initial Public Offering and Concurrent Private Placement Initiated Phase 2 Clinical Trial for Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis...
Algernon Logo 1.png
Algernon Pharmaceuticals Expands Its Research Program to Include Idiopathic Pulmonary Fibrosis
25 févr. 2019 07h00 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: BTHCF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen Announces Publication of Phase 2 Study Results Supporting the Potential of FG-3019 to Treat Patients With Idiopathic Pulmonary Fibrosis
11 mars 2016 08h00 HE | FibroGen, Inc.
SAN FRANCISCO, March 11, 2016 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN) (FibroGen) announced today that the European Respiratory Journal (“ERJ”) published on-line a manuscript...
CPF logo without tagline
Coalition for Pulmonary Fibrosis to Cease Operations
19 nov. 2015 10h25 HE | Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, Calif., Nov. 19, 2015 (GLOBE NEWSWIRE) -- "Never doubt that a small group of thoughtful, committed, citizens can change the world. Indeed, it is the only thing that ever has." -- Margaret...
CPF logo without tagline
SPORTS RADIO HOST, COMMERCIAL BANK VP, ST. JUDE, UTHSC DOCTORS, TEMPLE ISRAEL RABBI TO SPEAK AT BOTANIC GARDEN CEREMONY
16 juil. 2015 14h29 HE | Coalition for Pulmonary Fibrosis (CPF)
MEMPHIS, Tenn., July 16, 2015 (GLOBE NEWSWIRE) -- A deadly lung disease most have never heard of is lurking in the community and threatening the lives of some well-known Memphians as it has claimed...
CPF logo without tagline
CPF Celebrates Historic Year of Progress in Pulmonary Fibrosis
30 déc. 2014 14h05 HE | Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, Calif., Dec. 30, 2014 (GLOBE NEWSWIRE) -- The Coalition for Pulmonary Fibrosis (CPF) played an important role in much of the year's successes in Pulmonary Fibrosis (PF), helping to make...
Barbara Barrie photo
CORRECTION - Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis Community
16 oct. 2014 17h19 HE | Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- In its press release dated October 16, 2014 at 10:46 AM EST with the headline "Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis...
Barbara Barrie photo
Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis Community
16 oct. 2014 10h46 HE | Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- Patients, families and researchers alike have anticipated for months the U.S. Food and Drug Administration (FDA) decisions on two drugs for...